Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients by Vesa T. Väliaho, Iben Spanggaard

Get full text

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors by Kristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, Kristoffer Staal Rohrberg, Laurine Harsloef, Martin Hoejgaard, Ane Yde Schmidt, Ulrik Lassen, Ida Viller Tuxen, Jane Preuss Hasselby, Maria Rossing, Eric Santoni-Rugiu, Christina Westmose Yde, Morten Mau-Sørensen

Get full text

Mapping MAGE-A4 expression in solid cancers for targeted therapies by Christin Habigt, Sylvie Rottey, Iben Spanggaard, Juanita S. Lopez, Elena Garralda, Emiliano Calvo, Oliver Bechter, Oliver Bechter, Jayesh Desai, Rachel Galot, Leena Gandhi, Florian Heil, Natascha Rieder, Ivan Dimitrov, Iris Martinez Quetglas, Christian Heichinger, Nino Keshelava, Andreas Roller

Get full text

Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor) by Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, Sabine Wilson, Iakov I. Davydov, Nicolas Staedler, José Duarte, Iris Martinez Quetglas, Eveline Nüesch, Marta Cañamero, Evelyne Chesné, George Au-Yeung, Erika Hamilton, Stephanie Lheureux, Debra L. Richardson, Iben Spanggaard, Bruno Gomes, Izolda Franjkovic, Mark DeMario, Martin Kornacker, Katharina Lechner

Get full text